ABSTRACT Objective: Data is lacking about FOLFIRINOX use for advanced pancreatic ductal adenocarcinoma in emerging countries. The objective of this study was to report outcomes of efficacy and safety in the setting of a South American institution. Methods: Patients treated with FOLFIRINOX for metastatic or locally advanced pancreatic cancer at...